 | • レポートコード：MRC2303A119 • 出版社/出版日：Persistence Market Research / 2022年12月29日 • レポート形態：英文、PDF、159ページ • 納品方法：Eメール • 産業分類：食品 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Site Licence | ￥1,140,000 (USD7,600) | ▷ お問い合わせ |
| Enterprisewide | ￥1,590,000 (USD10,600) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Persistence Market Research社発行の当調査レポートでは、世界の乳児臨床栄養市場の現状について調査・分析し、エグゼクティブサマリー、市場概要、主要市場動向、主要成功要因、価格分析、需要分析・予測、市場背景、市場構造分析、競争分析、仮定、調査手法などの構成でまとめております。セグメント分析では、製品タイプ別（牛乳系、大豆系、オーガニック、プロバイオティクス/プレバイオティクス）、投与経路別（経口投与、経腸投与、静脈内投与）、地域別（北米、中南米、ヨーロッパ、南アジア＆太平洋、東アジア、中東/アフリカ）の情報が含まれています。なお、当市場の主要企業には、Abbott Laboratories、Baxter International、Nestle S.A.、Danone、Meiji Holdings Co., Ltd.、Fresenius SE & Co. KGaA、Reckitt Benckiser Group Plc、Perrigo Co. Plc、Ingredion Inc.、Solace Nutritionなどが含まれています。 ・エグゼクティブサマリー ・市場概要 ・主要市場動向 ・主要成功要因 ・価格分析 ・需要分析・予測 ・市場背景 ・世界の乳児臨床栄養市場規模：製品タイプ別 - 牛乳系乳児臨床栄養の市場規模 - 大豆系乳児臨床栄養の市場規模 - オーガニック乳児臨床栄養の市場規模 - プロバイオティクス/プレバイオティクス乳児臨床栄養の市場規模 ・世界の乳児臨床栄養市場規模：投与経路別 - 経口投与の市場規模 - 経腸投与の市場規模 - 静脈内投与の市場規模 ・世界の乳児臨床栄養市場規模：地域別 - 北米の乳児臨床栄養市場規模 - 中南米の乳児臨床栄養市場規模 - ヨーロッパの乳児臨床栄養市場規模 - 南アジア＆太平洋の乳児臨床栄養市場規模 - 東アジアの乳児臨床栄養市場規模 - 中東/アフリカの乳児臨床栄養市場規模 ・市場構造分析 ・競争分析 ・仮定 ・調査手法 |
Infant Clinical Nutrition Market: Report Scope
A latest market report by Persistence Market Research on the global infant clinical nutrition market evaluates the opportunities and current market scenario, providing insights and updates about corresponding segments involved in the market for the forecast period of 2023-2033. The report provides detailed assessment of key market dynamics, and comprehensive information about the structure of the market. This study contains detailed insights into how the market is anticipated to grow during the forecast period of 2023-2033.
The primary objective of the report is to provide insights regarding opportunities in the market that are supporting the transformation of global businesses associated with infant clinical nutrition. It is very important to consider that, in an ever-wavering economy, we provide estimated (Y-o-Y) year-on-year growth rate in addition to compound annual growth rate (CAGR) for overall forecasts, to enable readers better understand the analysis and evaluation of the market, and to discover lucrative opportunities in this space.
This report also provides an estimate of market size and corresponding revenue forecasts carried out in terms of absolute $ opportunity. It also offers actionable insights based on the future trends in the market. Furthermore, new and emerging players in the global infant clinical nutrition market can make use of the information presented in the study for effective business decisions, which will provide momentum to their businesses as well as the global market.
The study is relevant for manufacturers, suppliers, distributors, and investors in the infant clinical nutrition market. All stakeholders, as well as industry experts, researchers, journalists, and business researchers can leverage the information and data represented in the report.
Key Market Segments
Persistence Market Research’s report on the global infant clinical nutrition market offers information divided into three segments – product type, route of administration and region.
Product Type
Milk-Based
Soy-Based
Organic
Probiotic/Prebiotic
Route of Administration
Oral administration
Enteral administration
Intravenous administration
Region
North America
Latin America
Europe
East Asia
South Asia & Pacific
Middle East & Africa
Key Questions Answered in Study
Which region will hold the highest market share over the forecast period?
Which region is experiencing the highest growth (CAGR)?
Which factors are impacting the global infant clinical nutrition market?
What are the global trends impacting the market?
What strategies must emerge players adopt to capture opportunities in various regions in the market?
What is the structure of the global infant clinical nutrition market?
Research Methodology
Persistence Market Research is committed to providing unbiased market research solutions to its clients. The company follows a robust methodology for the deduction of data included in this report. A unique research methodology is utilized to conduct extensive research on the global infant clinical nutrition market, and reach conclusions about the future growth factors of the market. The research methodology comprises primary research methods coupled with secondary research methods, which ensures the accuracy and reliability of the conclusions in this report.
A demand-side approach is followed to estimate the sales of target products, followed by an in-depth supply-side assessment of value generated, key trends, and events over a predefined period. This methodology is based on standard market structures, methods, and definitions that are based on inputs from local sources in over six regions – North America, Latin America, Europe, East Asia, South Asia & Pacific, Middle East & Africa which Persistence Market Research considers for segmenting the global market. Statistics, characteristics, and variances are collected at a regional level, aggregated at the same level, and then synthesized at a worldwide level, to create global market measurements. Our main sources of research include:
Primary Research
Secondary Research
Trade Research
Social Media Research
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Technology Roadmap
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.1.1. Increasing Birth Rate with the Growing Number of Premature Births Creates Needs for Infant Nutrition Supplements
3.1.2. Advancements in the Nutritional Modifications in the Infant Food Products to Boost the Market Growth
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Product Adoption / Usage Analysis
4.2. Product USPs / Features
4.3. Strategic Promotional Strategies
5. Global Infant Clinical Nutrition Market – Pricing Analysis
5.1. Regional Pricing Trend Analysis, 2017-2022
5.2. Global Average Pricing Analysis Benchmark
6. Global Infant Clinical Nutrition Market Demand (in Value US$ Mn) Analysis 2018–2022 and Forecast, 2023–2033
6.1. Historical Market Value (US$ Mn) Analysis, 2018–2022
6.2. Current and Future Market Value (US$ Mn) Projections, 2023–2033
6.2.1. Y-o-Y Growth Trend Analysis
6.2.2. Absolute $ Opportunity Analysis
7. Market Background
7.1. Macro-Economic Factors
7.1.1. Global GDP Growth Outlook
7.1.2. Global Food & Beverage industry Overview
7.1.3. Global GDP and Infrastructure Investment
7.1.4. International Trade
7.1.5. Global Industry Outlook
7.2. Forecast Factors – Relevance & Impact
7.2.1. Top Companies Historical Growth
7.2.2. GDP Growth forecast
7.2.3. Manufacturing Industry forecast
7.2.4. Global Urbanization Growth Outlook
7.2.5. Business Climate
7.3. Global Food and Beverage Industry Overview
7.4. Global Dairy Industry Overview
7.5. Supply Chain & Value-Chain Analysis
7.5.1. Raw Material Suppliers
7.5.2. Product Manufacturers
7.5.3. Distribution Channel Industries
7.6. Policy Developments and Regulatory Scenario
7.6.1. The United States Food and Drug Administration (FDA)
7.6.2. Canadian Food Inspection Agency
7.6.3. European Food Safety Authority (EFSA)
7.6.4. The Food Safety and Standards Authority of India (FSSAI)
7.6.5. Ministry of Health, Labor and Welfare. (MHLW), Japan
7.6.6. National Health Commission (NHC), China
7.6.7. Food Standards Australia New Zealand (FSANZ)
7.7. Market Dynamics
7.7.1. Drivers
7.7.2. Restraints
7.7.3. Opportunity Analysis
7.8. Global Supply Demand Analysis
8. Global Infant Clinical Nutrition Market Analysis 2018–2022 and Forecast 2023–2033, by Product Type
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) By Product Type, 2018–2022
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2023–2033
8.3.1. Milk-Based
8.3.2. Soy-Based
8.3.3. Organic
8.3.4. Probiotic/Prebiotic
8.4. Market Attractiveness Analysis By Product Type
9. Global Infant Clinical Nutrition Market Analysis 2018–2022 and Forecast 2023–2033, By Route of Administration
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) and Volume Analysis By Route of Administration, 2018–2022
9.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Route of Administration, 2023–2033
9.3.1. Oral administration
9.3.2. Enteral administration
9.3.3. Intravenous administration
9.4. Market Attractiveness Analysis By Route of Administration
10. Global Infant Clinical Nutrition Market Analysis 2018–2022 and Forecast 2023–2033, by Region
10.1. Introduction
10.2. Historical Market Size (US$ Mn) and Volume Analysis By Region, 2018–2022
10.3. Current Market Size (US$ Mn) and Volume Analysis and Forecast By Region, 2023–2033
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. South Asia and Pacific
10.3.5. East Asia
10.3.6. Middle East and Africa (MEA)
10.4. Market Attractiveness Analysis By Region
11. North America Infant Clinical Nutrition Market Analysis 2018–2022 and Forecast 2023–2033
11.1. Introduction
11.2. Pricing Analysis
11.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2018–2022
11.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2023–2033
11.4.1. By Country
11.4.1.1. U.S.
11.4.1.2. Canada
11.4.2. By Product Type
11.4.3. By Route of Administration
11.5. Market Attractiveness Analysis
11.5.1. By Country
11.5.2. By Product Type
11.5.3. By Route of Administration
11.6. Market Trends
11.7. Key Market Participants – Intensity Mapping
11.8. Drivers and Restraints – Impact Analysis
12. Latin America Infant Clinical Nutrition Market Analysis 2018–2022 and Forecast 2023–2033
12.1. Introduction
12.2. Pricing Analysis
12.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2018–2022
12.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2023–2033
12.4.1. By Country
12.4.1.1. Brazil
12.4.1.2. Mexico
12.4.1.3. Argentina
12.4.1.4. Rest of Latin America
12.4.2. By Product Type
12.4.3. By Route of Administration
12.5. Market Attractiveness Analysis
12.5.1. By Country
12.5.2. By Product Type
12.5.3. By Route of Administration
12.6. Market Trends
12.7. Key Market Participants – Intensity Mapping
12.8. Drivers and Restraints – Impact Analysis
13. Europe Infant Clinical Nutrition Market Analysis 2018–2022 and Forecast 2023–2033
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2018–2022
13.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2023–2033
13.4.1. By Country
13.4.1.1. Germany
13.4.1.2. Italy
13.4.1.3. France
13.4.1.4. U.K.
13.4.1.5. Spain
13.4.1.6. BENELUX
13.4.1.7. Russia
13.4.1.8. Poland
13.4.1.9. Rest of Europe
13.4.2. By Product Type
13.4.3. By Route of Administration
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Product Type
13.5.3. By Route of Administration
13.6. Market Trends
13.7. Key Market Participants – Intensity Mapping
13.8. Drivers and Restraints – Impact Analysis
14. South Asia and Pacific Infant Clinical Nutrition Market Analysis 2018–2022 and Forecast 2023–2033
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2018–2022
14.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2023–2033
14.4.1. By Country
14.4.1.1. India
14.4.1.2. ASEAN
14.4.1.3. Oceania (Australia & New Zealand)
14.4.1.4. Rest of South Asia & Pacific
14.4.2. By Product Type
14.4.3. By Route of Administration
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Product Type
14.5.3. By Route of Administration
14.6. Market Trends
14.7. Key Market Participants – Intensity Mapping
14.8. Drivers and Restraints – Impact Analysis
15. East Asia Infant Clinical Nutrition Market Analysis 2018–2022 and Forecast 2023–2033
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2018–2022
15.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2023–2033
15.4.1. By Country
15.4.1.1. China
15.4.1.2. Japan
15.4.1.3. South Korea
15.4.2. By Product Type
15.4.3. By Route of Administration
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Product Type
15.5.3. By Route of Administration
15.6. Market Trends
15.7. Key Market Participants – Intensity Mapping
15.8. Drivers and Restraints – Impact Analysis
16. Middle East and Africa Infant Clinical Nutrition Market Analysis 2018–2022 and Forecast 2023–2033
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2018–2022
16.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2023–2033
16.4.1. By Country
16.4.1.1. GCC Countries
16.4.1.2. Turkey
16.4.1.3. Northern Africa
16.4.1.4. South Africa
16.4.1.5. Rest of Middle East and Africa
16.4.2. By Product Type
16.4.3. By Route of Administration
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Product Type
16.5.3. By Route of Administration
16.6. Market Trends
16.7. Key Market Participants – Intensity Mapping
16.8. Drivers and Restraints – Impact Analysis
17. Country Wise Infant Clinical Nutrition Market Analysis, 2023
17.1. Introduction
17.1.1. Market Value Proportion Analysis, By Key Countries
17.1.2. Global Vs. Country Growth Comparison
17.2. U.S. Infant Clinical Nutrition Market Analysis
17.2.1. By Product Type
17.2.2. By Route of Administration
17.3. Canada Infant Clinical Nutrition Market Analysis
17.3.1. By Product Type
17.3.2. By Route of Administration
17.4. Mexico Infant Clinical Nutrition Market Analysis
17.4.1. By Product Type
17.4.2. By Route of Administration
17.5. Brazil Infant Clinical Nutrition Market Analysis
17.5.1. By Product Type
17.5.2. By Route of Administration
17.6. Argentina Infant Clinical Nutrition Market Analysis
17.6.1. By Product Type
17.6.2. By Route of Administration
17.7. Germany Infant Clinical Nutrition Market Analysis
17.7.1. By Product Type
17.7.2. By Route of Administration
17.8. Italy Infant Clinical Nutrition Market Analysis
17.8.1. By Product Type
17.8.2. By Route of Administration
17.9. France Infant Clinical Nutrition Market Analysis
17.9.1. By Product Type
17.9.2. By Route of Administration
17.10. U.K. Infant Clinical Nutrition Market Analysis
17.10.1. By Product Type
17.10.2. By Route of Administration
17.11. Spain Infant Clinical Nutrition Market Analysis
17.11.1. By Product Type
17.11.2. By Route of Administration
17.12. Poland Infant Clinical Nutrition Market Analysis
17.12.1. By Product Type
17.12.2. By Route of Administration
17.13. Russia Infant Clinical Nutrition Market Analysis
17.13.1. By Product Type
17.13.2. By Route of Administration
17.14. China Infant Clinical Nutrition Market Analysis
17.14.1. By Product Type
17.14.2. By Route of Administration
17.15. Japan Infant Clinical Nutrition Market Analysis
17.15.1. By Product Type
17.15.2. By Route of Administration
17.16. S. Korea Infant Clinical Nutrition Market Analysis
17.16.1. By Product Type
17.16.2. By Route of Administration
17.17. India Infant Clinical Nutrition Market Analysis
17.17.1. By Product Type
17.17.2. By Route of Administration
17.18. Oceania (Australia and New Zealand) Infant Clinical Nutrition Market Analysis
17.18.1. By Product Type
17.18.2. By Route of Administration
17.19. Turkey Infant Clinical Nutrition Market Analysis
17.19.1. By Product Type
17.19.2. By Route of Administration
17.20. South Africa Infant Clinical Nutrition Market Analysis
17.20.1. By Product Type
17.20.2. By Route of Administration
18. Market Structure Analysis
18.1. Market Analysis by Tier of Companies (Infant Clinical Nutrition)
18.2. Market Share Analysis of Top Players
18.3. Market Presence Analysis
19. Competition Analysis
19.1. Competition Dashboard
19.2. Competition Benchmarking
19.3. Competition Deep Dive
19.3.1. Abbott Laboratories
19.3.1.1. Overview
19.3.1.2. Product Portfolio
19.3.1.3. Profitability by Market Segments (Product/Channel/Region)
19.3.1.4. Sales Footprint
19.3.1.5. Strategy Overview
19.3.2. Baxter International
19.3.2.1. Overview
19.3.2.2. Product Portfolio
19.3.2.3. Profitability by Market Segments (Product/Channel/Region)
19.3.2.4. Sales Footprint
19.3.2.5. Strategy Overview
19.3.3. Nestle S.A.
19.3.3.1. Overview
19.3.3.2. Product Portfolio
19.3.3.3. Profitability by Market Segments (Product/Channel/Region)
19.3.3.4. Sales Footprint
19.3.3.5. Strategy Overview
19.3.4. Danone
19.3.4.1. Overview
19.3.4.2. Product Portfolio
19.3.4.3. Profitability by Market Segments (Product/Channel/Region)
19.3.4.4. Sales Footprint
19.3.4.5. Strategy Overview
19.3.5. Meiji Holdings Co., Ltd.
19.3.5.1. Overview
19.3.5.2. Product Portfolio
19.3.5.3. Profitability by Market Segments (Product/Channel/Region)
19.3.5.4. Sales Footprint
19.3.5.5. Strategy Overview
19.3.6. Fresenius SE & Co. KGaA
19.3.6.1. Overview
19.3.6.2. Product Portfolio
19.3.6.3. Profitability by Market Segments (Product/Channel/Region)
19.3.6.4. Sales Footprint
19.3.6.5. Strategy Overview
19.3.7. Reckitt Benckiser Group Plc
19.3.7.1. Overview
19.3.7.2. Product Portfolio
19.3.7.3. Profitability by Market Segments (Product/Channel/Region)
19.3.7.4. Sales Footprint
19.3.7.5. Strategy Overview
19.3.8. Perrigo Co. Plc
19.3.8.1. Overview
19.3.8.2. Product Portfolio
19.3.8.3. Profitability by Market Segments (Product/Channel/Region)
19.3.8.4. Sales Footprint
19.3.8.5. Strategy Overview
19.3.9. Ingredion Inc.
19.3.9.1. Overview
19.3.9.2. Product Portfolio
19.3.9.3. Profitability by Market Segments (Product/Channel/Region)
19.3.9.4. Sales Footprint
19.3.9.5. Strategy Overview
19.3.10. Solace Nutrition
19.3.10.1. Overview
19.3.10.2. Product Portfolio
19.3.10.3. Profitability by Market Segments (Product/Channel/Region)
19.3.10.4. Sales Footprint
19.3.10.5. Strategy Overview
19.3.11. Others ( on Additional Request)
19.3.11.1. Overview
19.3.11.2. Product Portfolio
19.3.11.3. Profitability by Market Segments (Product/Channel/Region)
19.3.11.4. Sales Footprint
19.3.11.5. Strategy Overview
20. Assumptions and Acronyms Used
21. Research Methodology